"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention.
about
Surgery for cholangiocarcinoma: the role of liver transplantationPerformance characteristics of magnetic resonance cholangiography in the staging of malignant hilar stricturesThe rise of the FGFR inhibitor in advanced biliary cancer: the next cover of time magazine?Photodynamic therapy: Palliation and endoscopic technique in cholangiocarcinoma.Role of endoscopic ultrasonography in the evaluation of extrahepatic cholangiocarcinomaOutpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancerLong-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinomaA rare cause of dilated bile duct incidentally detected on imaging.Interleukin-2 gene-encoded stromal cells inhibit the growth of metastatic cholangiocarcinomas.Neurofibroma of the bile duct: a rare cause of obstructive jaundiceRadiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.Cholangiocarcinoma of the extrahepatic bile ducts.A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cellsNew insights on cholangiocarcinoma.A fatal case of primary basaloid squamous cell carcinoma in the intrahepatic bile ducts.Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus.Systemic Therapy of Cholangiocarcinoma.Cholangiocarcinoma: molecular pathways and therapeutic opportunitiesMicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.MiR-21 promotes intrahepatic cholangiocarcinoma proliferation and growth in vitro and in vivo by targeting PTPN14 and PTEN.TGF-β1 expression is associated with invasion and metastasis of intrahepatic cholangiocarcinoma.Recruited metastasis suppressor NM23-H2 attenuates expression and activity of peroxisome proliferator-activated receptor δ (PPARδ) in human cholangiocarcinoma.Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literatureDepth of tumor invasion better predicts prognosis than the current American Joint Committee on Cancer T classification for distal bile duct carcinoma.Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels.Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.Cholestatic liver disease. Recognizing the clinical signs.A Case of Common Bile Duct Cancer That Completely Responded to Combination Chemotherapy of Gemcitabine and TS-1.Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment.Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.Endoscopic transpapillary brush cytology and forceps biopsy in patients with hilar cholangiocarcinomaCholangiocarcinoma: a 7-year experience at a single center in Greece.A case of advanced intrahepatic cholangiocarcinoma successfully treated with chemosensitivity test-guided systemic chemotherapy.Photodynamic therapy is associated with an improvement in survival in patients with irresectable hilar cholangiocarcinoma.Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.Success of photodynamic therapy in palliating patients with nonresectable cholangiocarcinoma: A systematic review and meta-analysis.Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
P2860
Q24647147-993A348C-9C3C-42EA-8AD1-7EA91F1C7DE8Q24670141-5BCA1A31-CE98-4DE0-B781-9612E47D3D17Q28074145-ED32A4AF-764E-411B-B325-0EF8E13A203CQ30433853-A00D64F6-E724-46E8-A482-9D332C347293Q30436424-8362D644-6D2D-442D-92BC-44779633255FQ33372640-807C068B-41D7-4EF8-87A5-CB4E6DBEFA8AQ33633694-F378AE96-69D2-404C-A798-EBC8B1EB8C5BQ33691715-65E656B2-C29F-4B69-9F8F-26F3088678E7Q33866589-F68E6D80-9572-4B0D-B487-FCCF7AF60322Q33902382-D96B4088-B2B1-4737-9715-C8BAA346D1D7Q34002121-70DC2916-5E1F-4A83-A7E6-150CC4911661Q34110976-87D835BA-37A4-4B8A-9B54-A7CE25CE8EAEQ34212347-D875BD30-18FB-421D-9329-FB279EE582DBQ34391135-E7486231-5A1F-445F-AB19-4E08894088C6Q34454193-BC31F77F-17E9-4083-ADB7-340EC76738FAQ34486878-937CB788-0E22-497A-B52F-28568513B4A7Q34551877-989ECC32-A0FF-4B36-9A33-954086E01595Q34959174-0B83B7B0-A57F-44E9-B928-F9B7A18F6523Q35070803-7B00882A-C2C2-4BBD-A54A-31DB29C0C452Q35654552-265C9630-4C47-4937-B549-79DA33D1E1D9Q35742436-3B877C6E-4308-42B8-AA66-968EE7E29BFCQ35885365-8B4DE724-0453-4EAE-99A9-5285C3B9B9C5Q35956552-CD7C0982-6E9C-43BF-B563-E4FE5BF0E433Q36020107-2E9D70EB-4113-4FD0-AD48-30BCAD93E148Q36052356-CF2AAACC-B6CC-48FC-8C20-CC78BF4762ADQ36110741-1139C531-4505-4168-A532-509752796761Q36161907-72E27D25-98DC-41FA-B4FE-EE7F30D4CBD0Q36210966-42E0B887-90D4-4E93-B325-2B3D576926F6Q36245788-2F9C8051-1C5E-4BB3-9250-6C11BF213DE6Q36567737-C8F543E4-B5DD-4B81-BDCF-9BE4741C72E2Q36868758-BDFA828A-E05F-4CCB-80BD-15738288A852Q36900063-1470204F-94AD-48D9-8456-5B971B242E9CQ37174653-DAF2879A-A6D1-4BF4-8D3F-3A3CA41F7111Q37209942-9F030D0D-E9D0-44FA-918A-C8971980A302Q37386605-F806AD87-81F9-4D4F-B19A-5ACAF9A3E365Q37413339-F338CE69-3181-42E0-880A-1A942FE6DF0DQ37449364-8BFE7006-17E0-4729-A4E3-1B6205BDEA86Q37522695-2447F391-B4FC-4F22-872D-0CD7DDCD2386Q37662645-960A9DED-F887-4186-A243-24CFD22B51A7Q38004855-82A46528-92D4-480A-BA1E-7E0DD90558E0
P2860
"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
name
"Natural history" of unresecte ...... fter noncurative intervention.
@ast
"Natural history" of unresecte ...... fter noncurative intervention.
@en
"Natural history" of unresecte ...... fter noncurative intervention.
@nl
type
label
"Natural history" of unresecte ...... fter noncurative intervention.
@ast
"Natural history" of unresecte ...... fter noncurative intervention.
@en
"Natural history" of unresecte ...... fter noncurative intervention.
@nl
prefLabel
"Natural history" of unresecte ...... fter noncurative intervention.
@ast
"Natural history" of unresecte ...... fter noncurative intervention.
@en
"Natural history" of unresecte ...... fter noncurative intervention.
@nl
P2093
P356
P1476
"Natural history" of unresecte ...... fter noncurative intervention.
@en
P2093
A L Weaver
D M Nagorney
D R Farley
P304
P356
10.4065/70.5.425
P407
P577
1995-05-01T00:00:00Z